Targeted Therapy Combinations: VVIP, VIPOR, and VIPOR-P Clinical Trials
Update: 2024-04-11
Description
Dr. Melani discusses the latest updates from the VVIP, VIPOR, and VIPOR-P studies, which are clinical trials for non-Hodgkin's lymphoma. The goal of these studies is to improve the outcome for patients with relapsed or refractory lymphomas by using targeted therapy combinations. Targeted therapies block specific proteins that cancer cells need to grow and survive. The conversation also discusses these three clinical trials' design and treatment protocols.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
